552 related articles for article (PubMed ID: 17006890)
1. Haplotype matching is not an essential requirement to achieve remyelination of demyelinating CNS lesions.
Tepavcević V; Blakemore WF
Glia; 2006 Dec; 54(8):880-90. PubMed ID: 17006890
[TBL] [Abstract][Full Text] [Related]
2. Inflammation stimulates remyelination in areas of chronic demyelination.
Foote AK; Blakemore WF
Brain; 2005 Mar; 128(Pt 3):528-39. PubMed ID: 15699059
[TBL] [Abstract][Full Text] [Related]
3. Glial grafting for demyelinating disease.
Tepavcević V; Blakemore WF
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1775-95. PubMed ID: 16147541
[TBL] [Abstract][Full Text] [Related]
4. Endogenous remyelination is induced by transplant rejection in a viral model of multiple sclerosis.
Hatch MN; Schaumburg CS; Lane TE; Keirstead HS
J Neuroimmunol; 2009 Jul; 212(1-2):74-81. PubMed ID: 19477025
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
Woodruff RH; Fruttiger M; Richardson WD; Franklin RJ
Mol Cell Neurosci; 2004 Feb; 25(2):252-62. PubMed ID: 15019942
[TBL] [Abstract][Full Text] [Related]
6. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain.
Targett MP; Sussman J; Scolding N; O'Leary MT; Compston DA; Blakemore WF
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):199-206. PubMed ID: 8804021
[TBL] [Abstract][Full Text] [Related]
7. Glial cell transplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS.
Blakemore WF; Crang AJ; Franklin RJ; Tang K; Ryder S
Glia; 1995 Feb; 13(2):79-91. PubMed ID: 7649617
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells enhance the engraftment and myelinating ability of allogeneic oligodendrocyte progenitors in dysmyelinated mice.
Cristofanilli M; Harris VK; Zigelbaum A; Goossens AM; Lu A; Rosenthal H; Sadiq SA
Stem Cells Dev; 2011 Dec; 20(12):2065-76. PubMed ID: 21299379
[TBL] [Abstract][Full Text] [Related]
9. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.
Blakemore WF; Gilson JM; Crang AJ
Exp Neurol; 2003 Dec; 184(2):955-63. PubMed ID: 14769388
[TBL] [Abstract][Full Text] [Related]
10. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
Groves AK; Barnett SC; Franklin RJ; Crang AJ; Mayer M; Blakemore WF; Noble M
Nature; 1993 Apr; 362(6419):453-5. PubMed ID: 8464477
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated CNS demyelination II. Focal spinal cord lesions induced by implantation of an IgM antisulfatide-secreting hybridoma.
Rosenbluth J; Schiff R; Liang WL; Dou W
J Neurocytol; 2003 Mar; 32(3):265-76. PubMed ID: 14724389
[TBL] [Abstract][Full Text] [Related]
12. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.
Mothe AJ; Tator CH
Exp Neurol; 2008 Sep; 213(1):176-90. PubMed ID: 18586031
[TBL] [Abstract][Full Text] [Related]
13. Boundary cap cells are highly competitive for CNS remyelination: fast migration and efficient differentiation in PNS and CNS myelin-forming cells.
Zujovic V; Thibaud J; Bachelin C; Vidal M; Coulpier F; Charnay P; Topilko P; Baron-Van Evercooren A
Stem Cells; 2010 Mar; 28(3):470-9. PubMed ID: 20039366
[TBL] [Abstract][Full Text] [Related]
14. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
16. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
Zawadzka M; Franklin RJ
Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623
[TBL] [Abstract][Full Text] [Related]
17. Attempts to produce astrocyte cultures devoid of oligodendrocyte generating potential by the use of antimitotic treatment reveal the presence of quiescent oligodendrocyte precursors.
Crang AJ; Blakemore WF
J Neurosci Res; 1997 Jul; 49(1):64-71. PubMed ID: 9211990
[TBL] [Abstract][Full Text] [Related]
18. Minimally manipulated oligodendrocyte precursor cells retain exclusive commitment to the oligodendrocyte lineage following transplantation into intact and injured hippocampus.
Webber DJ; Compston A; Chandran S
Eur J Neurosci; 2007 Oct; 26(7):1791-800. PubMed ID: 17897393
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro.
Selvaraju R; Bernasconi L; Losberger C; Graber P; Kadi L; Avellana-Adalid V; Picard-Riera N; Baron Van Evercooren A; Cirillo R; Kosco-Vilbois M; Feger G; Papoian R; Boschert U
Mol Cell Neurosci; 2004 Apr; 25(4):707-21. PubMed ID: 15080898
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of T cell homing by down-regulation of CD62L and the induction of a Th-2 response as a method to prevent acute allograft rejection in mice.
Stremmel C; Sienel W; Eggeling S; Passlick B; Slavin A
Eur J Cardiothorac Surg; 2006 Aug; 30(2):362-9. PubMed ID: 16828564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
